silybin has been researched along with oxidopamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebadi, SA; Eyvari Brooshghalan, S; Haddadi, R; Mohajjel Nayebi, A; Sabahi, M; Sadeghian, Z | 1 |
1 other study(ies) available for silybin and oxidopamine
| Article | Year |
|---|---|
Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling.
Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Interleukin-6; Molecular Docking Simulation; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Rats; Silybin; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2023 |